Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Malignant Melanoma

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 55 articles: HTML format

Single Articles

April 2020
1. LIU X, Li Z, Li M, Chai J, et al
   Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF.
   Oncol Rep. 2020 Apr 15. doi: 10.3892/or.2020.7582.
   PubMed     Abstract available
   
   
   January 2020
2. KRAJEWSKI A, Gagat M, Zuryn A, Halas-Wisniewska M, et al
   Cyclin F is involved in response to cisplatin treatment in melanoma cell lines.
   Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7465.
   PubMed     Abstract available
   
   
   
3. MIERZEJEWSKA J, Szczygiel A, Anger-Gora N, Rossowska J, et al
   DeOacylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity.
   Oncol Rep. 2020;43:270-281.
   PubMed     Abstract available
   
   
   October 2019
4. RAHMAN MM, Lai YC, Husna AA, Chen HW, et al
   Transcriptome analysis of dog oral melanoma and its oncogenic analogy with human melanoma.
   Oncol Rep. 2019 Oct 25. doi: 10.3892/or.2019.7391.
   PubMed     Abstract available
   
   
   
5. LICARETE E, Rauca VF, Luput L, Patras L, et al
   The prednisolone phosphateinduced suppression of the angiogenic function of tumorassociated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
   Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7346.
   PubMed     Abstract available
   
   
   September 2019
6. HOU X, Pang Y, Li X, Yang C, et al
   Coreshell type thermonanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells.
   Oncol Rep. 2019 Sep 20. doi: 10.3892/or.2019.7329.
   PubMed     Abstract available
   
   
   
7. KUCERA J, Strnadova K, Dvorankova B, Lacina L, et al
   Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.
   Oncol Rep. 2019 Sep 17. doi: 10.3892/or.2019.7319.
   PubMed     Abstract available
   
   
   June 2019
8. MACZYNSKA J, Choromanska A, Kutkowska J, Kotulska M, et al
   Effect of electrochemotherapy with betulinic acid or cisplatin on regulation of heat shock proteins in metastatic human carcinoma cells in vitro.
   Oncol Rep. 2019;41:3444-3454.
   PubMed     Abstract available
   
   
   May 2019
9. WEI X, You X, Zhang J, Zhou C, et al
   miR21 inhibitor facilitates the anticancer activity of doxorubicin loaded nanometer in melanoma.
   Oncol Rep. 2019 May 22. doi: 10.3892/or.2019.7167.
   PubMed     Abstract available
   
   
   
10. YAO W, Li Y, Zeng L, Zhang X, et al
    Intratumoral injection of dendritic cells overexpressing interleukin12 inhibits melanoma growth.
    Oncol Rep. 2019 May 21. doi: 10.3892/or.2019.7165.
    PubMed     Abstract available
    
    
    February 2019
11. PAN Z, Qu C, Chen Y, Chen X, et al
    Bufotalin induces cell cycle arrest and cell apoptosis in human malignant melanoma A375 cells.
    Oncol Rep. 2019 Feb 26. doi: 10.3892/or.2019.7032.
    PubMed     Abstract available
    
    
    December 2018
12. KAWALA RA, Ramadhani FJ, Choi HJ, Lee EH, et al
    Kenalog modified by ionizing radiation induces intrinsic apoptosis mediated by elevated levels of reactive oxygen species in melanoma cancer.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6940.
    PubMed     Abstract available
    
    
    October 2018
13. YU H, Fu QR, Huang ZJ, Lin JY, et al
    Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway.
    Oncol Rep. 2018 Oct 29. doi: 10.3892/or.2018.6828.
    PubMed     Abstract available
    
    
    
14. MOU K, Ding M, Han D, Zhou Y, et al
    miR5905p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.
    Oncol Rep. 2018;40:2056-2066.
    PubMed     Abstract available
    
    
    
15. PENG Y, Jia L, Wang S, Cao W, et al
    Sonodynamic therapy improves antitumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.
    Oncol Rep. 2018;40:2163-2170.
    PubMed     Abstract available
    
    
    August 2018
16. ANDRE ND, Silva VAO, Watanabe MAE, De Lucca FL, et al
    [Corrigendum] Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth.
    Oncol Rep. 2018 Aug 14. doi: 10.3892/or.2018.6646.
    PubMed     Abstract available
    
    
    May 2018
17. CHENG Q, Du J, Xie L, Liu X, et al
    Inhibition of SOX4 induces melanoma cell apoptosis via downregulation of NF-kappaB p65 signaling.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6443.
    PubMed     Abstract available
    
    
    
18. WANG W, Li L, Chen F, Yang Y, et al
    Umbilical cordderived mesenchymal stem cells can inhibit the biological functions of melanoma A375 cells.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6446.
    PubMed     Abstract available
    
    
    
19. GAGAT M, Krajewski A, Grzanka D, Grzanka A, et al
    Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6435.
    PubMed     Abstract available
    
    
    
20. RYABAYA O, Prokofieva A, Khochenkov D, Abramov I, et al
    Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment.
    Oncol Rep. 2018 May 9. doi: 10.3892/or.2018.6430.
    PubMed     Abstract available
    
    
    
21. SI L, Yan X, Hao W, Ma X, et al
    Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
    Oncol Rep. 2018;39:2160-2170.
    PubMed     Abstract available
    
    
    April 2018
22. LI H, Chen J, Wang X, He M, et al
    Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stemlike cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6387.
    PubMed     Abstract available
    
    
    
23. WEI C, Lu N, Wang L, Zhang Y, et al
    Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation.
    Oncol Rep. 2018 Apr 4. doi: 10.3892/or.2018.6356.
    PubMed     Abstract available
    
    
    March 2018
24. SUN MY, Wang Y, Zhu J, Lv C, et al
    Critical role for nonGAP function of Galphas in RGS1mediated promotion of melanoma progression through AKT and ERK phosphorylation.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6341.
    PubMed     Abstract available
    
    
    February 2018
25. WANG Q, Chen J, Wang A, Sun L, et al
    Differentially expressed circRNAs in melanocytes and melanoma cells and their effect on cell proliferation and invasion.
    Oncol Rep. 2018 Feb 13. doi: 10.3892/or.2018.6263.
    PubMed     Abstract available
    
    
    
26. WAN R, Liu A, Hou X, Lai Z, et al
    Screening and antitumor effect of an antiCTLA4 nanobody.
    Oncol Rep. 2018;39:511-518.
    PubMed     Abstract available
    
    
    January 2018
27. CHEN XEPSILON, Chen P, Chen SS, Ma T, et al
    miR106b5p promotes cell cycle progression of malignant melanoma by targeting PTEN.
    Oncol Rep. 2018;39:331-337.
    PubMed     Abstract available
    
    
    December 2017
28. AKIYAMA Y, Kiyohara Y, Yoshikawa S, Otsuka M, et al
    Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.
    Oncol Rep. 2017 Dec 21. doi: 10.3892/or.2017.6173.
    PubMed     Abstract available
    
    
    November 2017
29. KANG K, Zhang J, Zhang X, Chen Z, et al
    MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
    Oncol Rep. 2017 Nov 2. doi: 10.3892/or.2017.6074.
    PubMed     Abstract available
    
    
    September 2017
30. CORDARO FG, De Presbiteris AL, Camerlingo R, Mozzillo N, et al
    Phenotype characterization of human melanoma cells resistant to dabrafenib.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5963.
    PubMed     Abstract available
    
    
    August 2017
31. WANG DM, Jiao X, Plotnikoff NP, Griffin N, et al
    Killing effect of methionine enkephalin on melanoma in vivo and in vitro.
    Oncol Rep. 2017 Aug 24. doi: 10.3892/or.2017.5918.
    PubMed     Abstract available
    
    
    
32. MONTI P, Ghiorzo P, Menichini P, Foggetti G, et al
    TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5903.
    PubMed     Abstract available
    
    
    July 2017
33. MENG F, Zhang Y, Li X, Wang J, et al
    Clinical significance of miR-138 in patients with malignant melanoma through targeting of PDK1 in the PI3K/AKT autophagy signaling pathway.
    Oncol Rep. 2017 Jul 19. doi: 10.3892/or.2017.5838.
    PubMed     Abstract available
    
    
    June 2017
34. FENG R, Gong J, Wu L, Wang L, et al
    MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5774.
    PubMed     Abstract available
    
    
    
35. CHEN L, Cao Y, Rong D, Wang Y, et al
    MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5740.
    PubMed     Abstract available
    
    
    
36. QIU Z, Xing L, Zhang X, Qiang X, et al
    CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor alpha based DNA vaccine.
    Oncol Rep. 2017;37:3441-3448.
    PubMed     Abstract available
    
    
    May 2017
37. SHI J, Guo B, Hui Q, Chang P, et al
    Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5678.
    PubMed     Abstract available
    
    
    
38. XU X, Yokoyama S, Hayakawa Y, Saiki I, et al
    Coptidis Rhizoma induces intrinsic apoptosis through BAX and BAK activation in human melanoma.
    Oncol Rep. 2017 May 26. doi: 10.3892/or.2017.5672.
    PubMed     Abstract available
    
    
    
39. AVRAM S, Coricovac DE, Pavel IZ, Pinzaru I, et al
    Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5658.
    PubMed     Abstract available
    
    
    April 2017
40. ROOMI MW, Kalinovsky T, Niedzwiecki A, Rath M, et al
    Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
    Oncol Rep. 2017 Apr 24. doi: 10.3892/or.2017.5597.
    PubMed     Abstract available
    
    
    March 2017
41. BAI M, Zhang M, Long F, Yu N, et al
    Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
    Oncol Rep. 2017 Mar 30. doi: 10.3892/or.2017.5537.
    PubMed     Abstract available
    
    
    
42. SIPOS E, Hegyi K, Treszl A, Steiber Z, et al
    Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
    Oncol Rep. 2017 Mar 8. doi: 10.3892/or.2017.5496.
    PubMed     Abstract available
    
    
    
43. PERDUCA M, Dalle Carbonare L, Bovi M, Innamorati G, et al
    Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL beta-trefoil.
    Oncol Rep. 2017 Mar 6. doi: 10.3892/or.2017.5493.
    PubMed     Abstract available
    
    
    February 2017
44. ZHAO G, Han X, Cheng W, Ni J, et al
    Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5450.
    PubMed     Abstract available
    
    
    January 2017
45. MADORSKY ROWDO FP, Baron A, von Euw EM, Mordoh J, et al
    In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
    Oncol Rep. 2017 Jan 13. doi: 10.3892/or.2017.5363.
    PubMed     Abstract available
    
    
    
46. GUARNERI C, Bevelacqua V, Polesel J, Falzone L, et al
    NFkappaB inhibition is associated with OPN/MMP9 downregulation in cutaneous melanoma.
    Oncol Rep. 2017 Jan 10. doi: 10.3892/or.2017.5362.
    PubMed     Abstract available
    
    
    December 2016
47. JIANG G, Li R, Tang J, Ma Y, et al
    Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells.
    Oncol Rep. 2016 Dec 29. doi: 10.3892/or.2016.5342.
    PubMed     Abstract available
    
    
    
48. PENG U, Wang Z, Pei S, Ou Y, et al
    ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells via induction of ER stress and inhibition of ERK activation.
    Oncol Rep. 2016 Dec 28. doi: 10.3892/or.2016.5340.
    PubMed     Abstract available
    
    
    
49. LUO L, Cui J, Feng Z, Li Y, et al
    Lentiviral-mediated overexpression of KCTD12 inhibits the proliferation of human uveal melanoma OCM-1 cells.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5325.
    PubMed     Abstract available
    
    
    November 2016
50. GU Y, Wang J, Peng L
    (-)-Oleocanthal exerts anti-melanoma activities and inhibits STAT3 signaling pathway.
    Oncol Rep. 2016 Nov 23. doi: 10.3892/or.2016.5270.
    PubMed     Abstract available
    
    
    
51. WANG E, Wang D, Li B, Ma H, et al
    Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/beta-catenin pathway.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5247.
    PubMed     Abstract available
    
    
    
52. LIU Y, Chu Z, Li Q, Peng B, et al
    Downregulation of Bmi-1 suppresses epithelialmesenchymal transition in melanoma.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5244.
    PubMed     Abstract available
    
    
    October 2016
53. OR CR, Su HL, Lee WC, Yang SY, et al
    Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo.
    Oncol Rep. 2016 Oct 25. doi: 10.3892/or.2016.5201.
    PubMed     Abstract available
    
    
    
54. ZHANG D, Li Z, Zhang Y, Tu C, et al
    miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5190.
    PubMed     Abstract available
    
    
    September 2016
55. CHEN J, Liu Y, Sun Q, Wang B, et al
    CYR61 suppresses growth of human malignant melanoma.
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5124.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: